You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Medtronic
Johnson and Johnson
Merck
Mallinckrodt

Last Updated: February 26, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Trehalose-6-Phosphate

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Trehalose-6-Phosphate?

Trehalose-6-Phosphate is an investigational drug.

There have been 9 clinical trials for Trehalose-6-Phosphate. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2016.

The most common disease conditions in clinical trials are Macular Edema, Depressive Disorder, and Muscular Dystrophies. The leading clinical trial sponsors are Bioblast Pharma Ltd., Mashhad University of Medical Sciences, and Samsung Medical Center.

There are fifteen US patents protecting this investigational drug and eighty-six international patents.

Recent Clinical Trials for Trehalose-6-Phosphate
TitleSponsorPhase
Mycose AdminiStration for HealIng Alzheimer NEuropathy (MASHIANE)Mashhad University of Medical SciencesPhase 1
Inflammation Reduction by TREhalose AdminisTrationMashhad Razavi HospitalPhase 2
Inflammation Reduction by TREhalose AdminisTrationNational Institute for Medical Research DevelopmentPhase 2

See all Trehalose-6-Phosphate clinical trials

Clinical Trial Summary for Trehalose-6-Phosphate

Top disease conditions for Trehalose-6-Phosphate
Top clinical trial sponsors for Trehalose-6-Phosphate

See all Trehalose-6-Phosphate clinical trials

US Patents for Trehalose-6-Phosphate

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Trehalose-6-Phosphate   Start Trial Modified gram positive bacteria and uses thereof INTREXON ACTOBIOTICS NV (Zwijnaarde, BE)   Start Trial
Trehalose-6-Phosphate   Start Trial Processes of producing fermentation products NOVOZYMES A/S (Bagsvaerd, DK)   Start Trial
Trehalose-6-Phosphate   Start Trial Modified gram positive bacteria and uses thereof INTREXON ACTOBIOTICS NV (Zwijnaarde, BE)   Start Trial
Trehalose-6-Phosphate   Start Trial Production of trehalose in plants Mogen International NV (Leiden, NL)   Start Trial
Trehalose-6-Phosphate   Start Trial OtsA gene encoding trehalose-6-phosphate synthase from a coryneform bacterium Ajinomoto Co. Inc. (Tokyo, JP)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Trehalose-6-Phosphate

Drugname Country Document Number Estimated Expiration Related US Patent
Trehalose-6-Phosphate Denmark DK2758512 2031-09-23   Start Trial
Trehalose-6-Phosphate European Patent Office EP2758512 2031-09-23   Start Trial
Trehalose-6-Phosphate Spain ES2676707 2031-09-23   Start Trial
Trehalose-6-Phosphate Hungary HUE038830 2031-09-23   Start Trial
Trehalose-6-Phosphate Japan JP2014526266 2031-09-23   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Medtronic
Johnson and Johnson
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.